{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:42:28Z","timestamp":1785757348642,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["C2020206044"],"award-info":[{"award-number":["C2020206044"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bbrc.2022.07.030","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T02:02:26Z","timestamp":1657764146000},"page":"162-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Makisterone A attenuates experimental cholestasis by activating the farnesoid X receptor"],"prefix":"10.1016","volume":"623","author":[{"given":"Peiyuan","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4869-3809","authenticated-orcid":false,"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.07.030_bib1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.biopha.2017.02.084","article-title":"Paeoniflorin attenuates ANIT-induced cholestasis by inhibiting apoptosis in\u00a0vivo via mitochondria-dependent pathway","volume":"89","author":"Zhou","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2022.07.030_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2022.07.030_bib3","first-page":"1","article-title":"Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2022.07.030_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jep.2017.07.031","article-title":"Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes","volume":"209","author":"Xu","year":"2017","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/aps.2016.86","article-title":"Sweroside ameliorates \u03b1-naphthylisothiocyanate-induced cholestatic liver injury in mice by regulating bile acids and suppressing pro-inflammatory responses","volume":"37","author":"Yang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbrc.2022.07.030_bib6","first-page":"211","article-title":"Targeted bile acids and gut microbiome profiles reveal the hepato-protective effect of WZ tablet (Schisandra sphenanthera extract) against LCA-induced cholestasis","volume":"18","author":"Dong-Shun","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bbrc.2022.07.030_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2015.08.029","article-title":"Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism","volume":"765","author":"Chen","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2022.07.030_bib10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2022.07.030_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116046","article-title":"Molecular basis of bile acid-FXR-FGF15\/19 signaling Axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2022.07.030_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in Health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2022.07.030_bib13","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.bcp.2005.03.019","article-title":"Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor","volume":"69","author":"Campana","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.12.018","article-title":"Developments in bile salt based therapies: a critical overview","volume":"161","author":"Donkers","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib15","doi-asserted-by":"crossref","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","article-title":"HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine","volume":"49","author":"Fang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2022.07.030_bib16","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154229","article-title":"KLF10 promotes nonalcoholic steatohepatitis progression through transcriptional activation of zDHHC7","volume":"23","author":"Yang","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbrc.2022.07.030_bib17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00125-021-05616-y","article-title":"MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1\/Akt signalling pathway","volume":"65","author":"Yang","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2022.07.030_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12967-020-02372-2","article-title":"Whole blood transcriptomic investigation identifies long non-coding RNAs as regulators in sepsis","volume":"18","author":"Cheng","year":"2020","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.bbrc.2022.07.030_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24091685","article-title":"Dihydropyrazole derivatives containing benzo oxygen heterocycle and sulfonamide moieties selectively and potently inhibit COX-2: design, synthesis, and anti-colon cancer activity evaluation","volume":"24","author":"Yan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2022.07.030_bib20","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1039\/c3ob41161c","article-title":"Discovery of 4,6-substituted-(diaphenylamino)quinazolines as potent c-Src inhibitors","volume":"11","author":"Li","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bbrc.2022.07.030_bib21","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/bph.15429","article-title":"Tectorigenin alleviates intrahepatic cholestasis by inhibiting hepatic inflammation and bile accumulation via activation of PPAR\u03b3","volume":"178","author":"Xiang","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.785403","article-title":"Pterostilbene alleviates cholestasis by promoting SIRT1 activity in hepatocytes and macrophages","volume":"12","author":"Ma","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BST20210658","article-title":"Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders","volume":"50","author":"Molinaro","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrc.2022.07.030_bib25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1136\/gutjnl-2016-311915","article-title":"The gut-adherent microbiota of PSC-IBD is distinct to that of IBD","volume":"66","author":"Quraishi","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2022.07.030_bib26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s10620-006-9544-z","article-title":"Abnormal intestinal permeability in primary biliary cirrhosis","volume":"51","author":"Feld","year":"2006","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2022.07.030_bib27","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/s41467-018-03764-1","article-title":"Macrophage-derived IL-1\u03b2\/NF-\u03baB signaling mediates parenteral nutrition-associated cholestasis","volume":"9","author":"El Kasmi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2022.07.030_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1126\/science.1237931","article-title":"Makisterone A:a 28-carbon hexahydroxy molting hormone from the embryo of the milkweed bug","volume":"190","author":"Kaplanis","year":"1975","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbrc.2022.07.030_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1673\/031.003.0701","article-title":"Practical uses for ecdysteroids in mammals including humans: an update","volume":"3","author":"Lafont","year":"2003","journal-title":"J.\u00a0Insect Sci."},{"key":"10.1016\/j.bbrc.2022.07.030_bib30","first-page":"75","article-title":"[Mechanisms of genoprotective action of a phytoecdysteroid drug(BTK-8L) in chromatin damage by tetrachloromethane]","volume":"65","author":"Gubski\u012d Iu","year":"1993","journal-title":"Ukr. Biokhim. Zh."},{"key":"10.1016\/j.bbrc.2022.07.030_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1520-6327(1999)41:3<156::AID-ARCH7>3.0.CO;2-Q","article-title":"20-hydroxyecdysone as a human lymphocyte and neutrophil modulator: in\u00a0vitro evaluation","volume":"41","author":"Trenin","year":"1999","journal-title":"Arch. Insect Biochem. Physiol."},{"key":"10.1016\/j.bbrc.2022.07.030_bib32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14712598.2.5.525","article-title":"Ecdysone-controlled expression of transgenes","volume":"2","author":"Graham","year":"2002","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2022.07.030_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2022.07.030_bib34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbrc.2022.07.030_bib35","doi-asserted-by":"crossref","first-page":"11323","DOI":"10.1073\/pnas.0604772103","article-title":"Benefit of farnesoid X receptor inhibition in obstructive cholestasis","volume":"103","author":"Stedman","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2022.07.030_bib36","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2022.07.030_bib37","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db11-0030","article-title":"Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity","volume":"60","author":"Prawitt","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2022.07.030_bib38","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2022.07.030_bib39","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.1074\/jbc.M111.248203","article-title":"Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure","volume":"286","author":"Watanabe","year":"2011","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22009998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22009998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:21:16Z","timestamp":1757766076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22009998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"alternative-id":["S0006291X22009998"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.030","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Makisterone A attenuates experimental cholestasis by activating the farnesoid X receptor","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}